PH13467A - Ophthalmic composition containing t-butylamino-3-(4-)morpholino-1,2,5-thiadoazol-3-yloxy)-2-propanol hydrogen maleate - Google Patents

Ophthalmic composition containing t-butylamino-3-(4-)morpholino-1,2,5-thiadoazol-3-yloxy)-2-propanol hydrogen maleate

Info

Publication number
PH13467A
PH13467A PH18931A PH18931A PH13467A PH 13467 A PH13467 A PH 13467A PH 18931 A PH18931 A PH 18931A PH 18931 A PH18931 A PH 18931A PH 13467 A PH13467 A PH 13467A
Authority
PH
Philippines
Prior art keywords
thiadoazol
butylamino
yloxy
morpholino
composition containing
Prior art date
Application number
PH18931A
Other languages
English (en)
Inventor
C Stone
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PH13467A publication Critical patent/PH13467A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PH18931A 1975-09-26 1976-09-22 Ophthalmic composition containing t-butylamino-3-(4-)morpholino-1,2,5-thiadoazol-3-yloxy)-2-propanol hydrogen maleate PH13467A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61711875A 1975-09-26 1975-09-26

Publications (1)

Publication Number Publication Date
PH13467A true PH13467A (en) 1980-05-15

Family

ID=24472326

Family Applications (1)

Application Number Title Priority Date Filing Date
PH18931A PH13467A (en) 1975-09-26 1976-09-22 Ophthalmic composition containing t-butylamino-3-(4-)morpholino-1,2,5-thiadoazol-3-yloxy)-2-propanol hydrogen maleate

Country Status (12)

Country Link
AU (1) AU513280B2 (fr)
BE (1) BE846574A (fr)
CY (1) CY1023A (fr)
GB (1) GB1524405A (fr)
HK (1) HK67579A (fr)
IE (1) IE44167B1 (fr)
IL (1) IL50477A (fr)
KE (1) KE2990A (fr)
MY (1) MY8000138A (fr)
NZ (1) NZ182022A (fr)
PH (1) PH13467A (fr)
ZA (1) ZA765752B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
US4402976A (en) 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations

Also Published As

Publication number Publication date
NZ182022A (en) 1978-12-18
IE44167B1 (en) 1981-08-26
KE2990A (en) 1979-09-28
GB1524405A (en) 1978-09-13
MY8000138A (en) 1980-12-31
IE44167L (en) 1977-03-26
ZA765752B (en) 1978-05-30
IL50477A0 (en) 1976-11-30
BE846574A (fr) 1977-03-24
HK67579A (en) 1979-09-28
CY1023A (en) 1980-08-01
IL50477A (en) 1979-09-30
AU1771476A (en) 1978-03-23
AU513280B2 (en) 1980-11-27

Similar Documents

Publication Publication Date Title
IL49229A0 (en) Novel polyamines,their preparation and their use as stabilizers for polyolefine compositions
PH20254A (en) 1,2 dihydro-2-oxo-(pyridiny,) nicotinanide
SG3185G (en) Compositions containing 1,3-dimethyl-5-aminoadamantane
NZ182692A (en) Fungicidal composition mixtures containing 1-substituted-1,2,4-triazdes
GB2011917B (en) Rubber compositions containing 1,2-polybutadience
IL58478A0 (en) Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines
GR60365B (en) Resin compositions containing o,o,o'o'-tetramethyl-o,o'-thiodi-p-phenylene phosphorothioate
JPS5257327A (en) Germicidal composition
AU507763B2 (en) Antifungal compositions
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
NZ183651A (en) Tribalo-n-alkyl-2',4',6'-trinitrodiphenylamines
AU513280B2 (en) Ophthalmic composition containing T-Butylamino-3-(4-Morpholino-1, 2, 5-Thiadiazol-3-yloxy)-2-propanol hydrogen maleate
GB1532697A (en) 2,3-dihydroergolines
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
GB1557694A (en) 2,9 dichlorquinacridone
EG12183A (en) 2-chloro-n-isoproyl-2',3'-imethylacetanilide
GB1554021A (en) 4,5-didehydroprostaglandins
GB1483330A (en) 2,5-dimethoxy-4-chloroaniline
GB1554925A (en) 2,3-methyl-eneprostaglandins
IL49340A (en) Fungicidal compositions containing 1-aryl-5-alkylidene-2,4-dioxo-imidazolidines
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
AU1483576A (en) 16,16-dimethyl-prostaglandins
GB1556249A (en) 1'h-androsta(16,17)cyclopentene-3'-ones
AU1346176A (en) 1,2,3,4-tetrahydro-4-oxo-%or-oxy-<-1-naphthylureas
NZ182228A (en) -1,2,4-triazol-1-yl- -alkylcarbonyl-thiophenes and fungicidal compositions